S.C. Financial Services’s Gilead Sciences GILD Stock Holding History

S.C. Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$273K	Buy	+3,176	New	+$252K	0.42%	78

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

S.C. Financial Services's GILD Position: Q4 2022 in Review

S.C. Financial Services opened a new position in Gilead Sciences (GILD) in Q4 2022: 3,176 shares worth $273K. The stake represents 0.42% of the portfolio and ranks #78 among its holdings.

1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

S.C. Financial Services held 3,176 shares of Gilead Sciences worth $273K as of Q4 2022.
Gilead Sciences was a new S.C. Financial Services position in Q4 2022.
Gilead Sciences made up 0.42% of S.C. Financial Services's portfolio in Q4 2022, its #78 holding.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on S.C. Financial Services's 13F filing for Q4 2022, filed 20 Jan 2023.